Bertagna X - Search Results

1

Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors.

Boulle N, Baudin E, Gicquel C, Logié A, Bertherat J, Penfornis A, Bertagna X, Luton JP, Schlumberger M, Le Bouc Y. Boulle N, et al. Among authors: bertagna x. Eur J Endocrinol. 2001 Jan;144(1):29-36. doi: 10.1530/eje.0.1440029. Eur J Endocrinol. 2001. PMID: 11174834

2

Cyclin E correlates with malignancy and adverse prognosis in adrenocortical tumors.

Tissier F, Louvel A, Grabar S, Hagnéré AM, Bertherat J, Vacher-Lavenu MC, Dousset B, Chapuis Y, Bertagna X, Gicquel C. Tissier F, et al. Among authors: bertagna x. Eur J Endocrinol. 2004 Jun;150(6):809-17. doi: 10.1530/eje.0.1500809. Eur J Endocrinol. 2004. PMID: 15191351

3

Clonal analysis of human adrenocortical carcinomas and secreting adenomas.

Gicquel C, Leblond-Francillard M, Bertagna X, Louvel A, Chapuis Y, Luton JP, Girard F, Le Bouc Y. Gicquel C, et al. Among authors: bertagna x. Clin Endocrinol (Oxf). 1994 Apr;40(4):465-77. doi: 10.1111/j.1365-2265.1994.tb02485.x. Clin Endocrinol (Oxf). 1994. PMID: 7910530

4

Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors.

Gicquel C, Bertagna X, Schneid H, Francillard-Leblond M, Luton JP, Girard F, Le Bouc Y. Gicquel C, et al. Among authors: bertagna x. J Clin Endocrinol Metab. 1994 Jun;78(6):1444-53. doi: 10.1210/jcem.78.6.7911125. J Clin Endocrinol Metab. 1994. PMID: 7911125

5

Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors.

Gicquel C, Raffin-Sanson ML, Gaston V, Bertagna X, Plouin PF, Schlumberger M, Louvel A, Luton JP, Le Bouc Y. Gicquel C, et al. Among authors: bertagna x. J Clin Endocrinol Metab. 1997 Aug;82(8):2559-65. doi: 10.1210/jcem.82.8.4170. J Clin Endocrinol Metab. 1997. PMID: 9253334

6

High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors.

Bourcigaux N, Gaston V, Logié A, Bertagna X, Le Bouc Y, Gicquel C. Bourcigaux N, et al. Among authors: bertagna x. J Clin Endocrinol Metab. 2000 Jan;85(1):322-30. doi: 10.1210/jcem.85.1.6303. J Clin Endocrinol Metab. 2000. PMID: 10634406

7

Pathogenesis of adrenocortical incidentalomas and genetic syndromes associated with adrenocortical neoplasms.

Gicquel C, Bertherat J, Le Bouc Y, Bertagna X. Gicquel C, et al. Among authors: bertagna x. Endocrinol Metab Clin North Am. 2000 Mar;29(1):1-13, vii. doi: 10.1016/s0889-8529(05)70112-2. Endocrinol Metab Clin North Am. 2000. PMID: 10732260 Review.

8

Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.

Gicquel C, Bertagna X, Gaston V, Coste J, Louvel A, Baudin E, Bertherat J, Chapuis Y, Duclos JM, Schlumberger M, Plouin PF, Luton JP, Le Bouc Y. Gicquel C, et al. Among authors: bertagna x. Cancer Res. 2001 Sep 15;61(18):6762-7. Cancer Res. 2001. PMID: 11559548

9

Recent advances in the pathogenesis of adrenocortical tumours.

Gicquel C, Bertagna X, Le Bouc Y. Gicquel C, et al. Among authors: bertagna x. Eur J Endocrinol. 1995 Aug;133(2):133-44. doi: 10.1530/eje.0.1330133. Eur J Endocrinol. 1995. PMID: 7655635 Review. No abstract available.

10

Oncogenic mutations of alpha-Gi2 protein are not determinant for human adrenocortical tumourigenesis.

Gicquel C, Dib A, Bertagna X, Amselem S, Le Bouc Y. Gicquel C, et al. Among authors: bertagna x. Eur J Endocrinol. 1995 Aug;133(2):166-72. doi: 10.1530/eje.0.1330166. Eur J Endocrinol. 1995. PMID: 7655640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters